Citius Oncology CTOR

NASDAQ CTOR

$0.94 +0.01 (+1.17%)

As of: Sep 9, 2026 · 3:59 PM EDT

Citius Oncology (CTOR) EBT Margin (QoQ) (2026)

Analysis

Citius Oncology (CTOR) EBT Margin (QoQ) (2026) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Amgen	211.73 Bn	197.74 Bn	7.24 Bn
2	Gilead Sciences	180.92 Bn	177.74 Bn	6.22 Bn
3	Vertex Pharmaceuticals	132.16 Bn	124.30 Bn	2.84 Bn
4	Regeneron Pharmaceuticals	82.89 Bn	74.90 Bn	3.93 Bn
5	Argenx Se	61.41 Bn	56.23 Bn	1.37 Bn
6	Moderna	53.99 Bn	48.85 Bn	52.00 Mn
7	Alnylam Pharmaceuticals	34.48 Bn	31.18 Bn	992.69 Mn
8	Biogen	31.15 Bn	29.86 Bn	1.96 Bn
9	Roivant Sciences	30.05 Bn	30.05 Bn	1.16 Mn
10	Citius Oncology	101.41 Mn	101.41 Mn	1.00 Mn

Historic Data

Historic Data

Download Data

Date	Value
Jun 30, 2026	100,526.00
Mar 31, 2026	-147,623.00

Citius Oncology

NASDAQ: CTOR

$0.94 ▲ +0.01 (+1.17%)

Sep 9, 2026 · 3:59 PM EDT